Products
Antibiotic Stewardship
Apr 1, 2022 2:20pm ‐ Apr 1, 2022 3:20pm
Antibiotic resistance is one of the greatest public health threats. Approximately 2 million people become sick each year with antibiotic resistant infections and the costs associated with antibiotic resistance are rising. Inappropriate and indiscriminate use of antibiotics has led to fewer options for providers. This presentation discusses antibiotic stewardship and how it is linked to infection prevention. It also discusses the core principles of stewardship, common overly prescribed antibiotics and antibiotic stewardship programs.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 4/3/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christina Hicks, MS, APRN, WHNP-BC discloses that she is a consultant for Urovant Sciences, Ltd.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to recognize their role in reducing antibiotic resistance in healthcare settings.
Speaker(s):
- Margaret McLean, MSN, APRN, ACNS-BC, Adult Clinical Nurse Specialist, University of Texas Southwestern Medical Center
APP Panel Discussion
Apr 1, 2022 3:25pm ‐ Apr 1, 2022 4:25pm
This advanced practice panel consists of speakers from a genitourinary medical oncology practice, a private urology practice, urgent care/general urology practice, as well as a provider who co-owns a continence solutions company. They briefly discuss their experience and job responsibilities in their respective practices.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 4/3/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christina Hicks, MS, APRN, WHNP-BC discloses that she is a consultant for Urovant Sciences, Ltd.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Melanie Schlittenhardt, DNP, APRN, FNP, CUNP discloses that she receives salary as the owner of Pelican Health, a pelvic health clinic.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to consider information gathered from the panel of practitioners to implement ideas for improvement into their own respective practices.
Speaker(s):
- Rachael Medrano, APRN, FNP-C, Nurse Practitioner, University of Texas Southwestern Medical Center
- Lisa Zambrano, BSN, RN, ANP-C, MS, CUNP
- Teresa Sanders, MPAS, PA-C, Physician Assistant, University of Texas Southwestern Medical Center
- Melanie Schlittenhardt, DNP, APRN, FNP, CUNP, Family Nurse Practitioner, Pelican Health
- Heidi Turpen, MS, MPAS, PA-C, Physician Assistant, University of Texas Southwestern Medical Center
Bladder Preservation Approaches in Muscle Invasive Bladder Cancer: Where Are We Headed After 40+ Years of Trials?
Apr 2, 2022 7:15am ‐ Apr 2, 2022 8:30am
Muscle invasive bladder cancer is a lethal disease with substantial quality of life impacts of the ‘standard’ cystectomy approach. Chemoradiation based bladder preservation strategies have demonstrated equitable outcomes in >40 years of studies with ongoing novel integration of immunotherapy promising further improvements. Learn the available data, flexibility of available regimens, and practical steps for ensuring high quality outcomes in practice.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 4/3/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christina Hicks, MS, APRN, WHNP-BC discloses that she is a consultant for Urovant Sciences, Ltd.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Neil Desai, MD, MHS discloses that he is a consultant for Boston Scientific and receives clinical trial funding for prostate cancer (not related to presentation content).
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to implement a standardized discussion of bladder preservation therapy and workflow in treatment of bladder cancer as an equitable alternative to cystectomy in selected patients.
Speaker(s):
- Neil Desai, MD, MHS, Associate Professor, University of Texas Southwestern Medical Center
MRI/TRUS Fusion Prostate Biopsy
Apr 2, 2022 10:30am ‐ Apr 2, 2022 11:30am
This presentation provides a brief review of MRI imaging of the prostate, discusses indications for prostate MRI, and then provides information about MRI/TRUS fusion biopsy of the prostate.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 4/3/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christina Hicks, MS, APRN, WHNP-BC discloses that she is a consultant for Urovant Sciences, Ltd.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to describe the evolution of imaging and biopsy techniques for detecting prostate cancer.
Speaker(s):
- Brad Hornberger, MPAS, PA-C, Physician Assistant, University of Texas Southwestern Medical Center
Lichenoid Vulvar Eruptions
Apr 2, 2022 10:30am ‐ Apr 2, 2022 11:30am
Lichen simplex chronicus, lichen sclerosus, and lichen planus may all sound similar but present very differently. This session uses a case-based approach to explore the clinical presentation and treatment regimens to help you confidently diagnose patients with a lichenoid eruption.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 4/3/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christina Hicks, MS, APRN, WHNP-BC discloses that she is a consultant for Urovant Sciences, Ltd.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to discuss the clinical presentation of and treatment regimens to confidently diagnose patients with a lichenoid vulvar eruption.
Speaker(s):
- Melissa Mauskar, MD, Assistant Professor, University of Texas Southwestern Medical Center
Neurogenic Bladder: Understanding Etiology, Work-up and Management
Apr 2, 2022 11:40am ‐ Apr 2, 2022 12:40pm
This lecture serves as a primer to understand how neurologic diseases can manifest as urologic issues. Preliminary understanding of the neurologic connections to voiding dysfunction and the work-up and diagnosis of patients with neurogenic voiding dysfunction. Discussion on how to enfold the new AUA’s neurogenic lower urinary tract dysfunction guidelines into daily practice.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 4/3/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christina Hicks, MS, APRN, WHNP-BC discloses that she is a consultant for Urovant Sciences, Ltd.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to distinguish between the different etiologies and consequences of neurogenic bladder.
Speaker(s):
- Ramy Goueli, MD, MHS, Assistant Professor, University of Texas Southwestern Medical Center
DISCOVER THE IMPACT OF GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment
Apr 2, 2022 1:15pm ‐ Apr 2, 2022 2:00pm
Immunotherapy in Cancer
Apr 2, 2022 2:10pm ‐ Apr 2, 2022 3:10pm
Immunotherapy has been integrated into the management of many primary cancers with great outcomes. This talk provides the latest advances in the use of immunotherapies for urologic and other primary malignancies.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 4/3/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christina Hicks, MS, APRN, WHNP-BC discloses that she is a consultant for Urovant Sciences, Ltd.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to discuss the latest advances in the use of immunotherapies for urologic and other primary malignancies.
Speaker(s):
- Puneeth Iyengar, MD, PhD, Associate Professor and Chief of Thoracic Radiation Oncology, University of Texas Southwestern Medical Center
Renal Cell CA
Apr 2, 2022 3:20pm ‐ Apr 2, 2022 4:20pm
This presentation discusses the anatomy, epidemiology, histology, risk factors, clinical presentation, workup, staging and management options for all stages of kidney cancer with a focus on new and emerging treatment strategies utilizing stereotactic radiation and immunotherapy.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 4/3/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christina Hicks, MS, APRN, WHNP-BC discloses that she is a consultant for Urovant Sciences, Ltd.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to include kidney cancer in their differential diagnosis of appropriate patients with the knowledge of presentation, diagnosis and work-up, staging and overall management of each stage of kidney cancer.
Speaker(s):
- Raquibul Hannan, MD, PhD, Associate Professor, University of Texas Southwestern Medical Center
Trends in Pediatric Stone Formation and Management
Apr 2, 2022 3:20pm ‐ Apr 2, 2022 4:20pm
Current trends in pediatric stone formation and recommendations for evaluation and treatment are discussed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 4/3/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christina Hicks, MS, APRN, WHNP-BC discloses that she is a consultant for Urovant Sciences, Ltd.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
After completing this education activity, the learner will be able to identify the following regarding pediatric kidney stones: epidemiology, trends, inborn errors of metabolism, diagnostic modalities, metabolic work-up, surgical approach, potential long-term concerns, and ongoing research.
Speaker(s):
- Meredith Alley, PA-C, Physician Assistant, Children's Hospital of Philadelphia